Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,820 | 138 | 98.3% |
| Gift | $24.44 | 1 | 0.9% |
| Education | $23.07 | 2 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $660.83 | 28 | $0 (2024) |
| Lilly USA, LLC | $286.05 | 14 | $0 (2024) |
| Ardelyx, Inc. | $254.20 | 12 | $0 (2024) |
| Novo Nordisk Inc | $229.69 | 15 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $123.07 | 6 | $0 (2024) |
| Daiichi Sankyo Inc. | $109.55 | 4 | $0 (2023) |
| Exact Sciences Corporation | $108.16 | 5 | $0 (2024) |
| Boston Scientific Corporation | $104.65 | 3 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $81.47 | 5 | $0 (2024) |
| Janssen Biotech, Inc. | $73.69 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,250 | 62 | Lilly USA, LLC ($245.76) |
| 2023 | $785.65 | 43 | ABBVIE INC. ($214.78) |
| 2022 | $593.34 | 29 | ABBVIE INC. ($147.59) |
| 2021 | $238.01 | 7 | AbbVie Inc. ($176.45) |
All Payment Transactions
141 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: Inflammation | ||||||
| 12/12/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: Pulmonology | ||||||
| 11/21/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/19/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $25.59 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: DIABETES | ||||||
| 11/07/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/31/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Cardiology | ||||||
| 10/24/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Hematology | ||||||
| 10/22/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/17/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: Oncology | ||||||
| 10/10/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: Diabetes | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Respiratory | ||||||
| 09/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $4.53 | General |
| Category: Obesity | ||||||
| 09/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $11.77 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: DIABETES | ||||||
| 09/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Cardio-renal | ||||||
| 08/29/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Inflammation | ||||||
| 08/26/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $2.73 | General |
| Category: Obesity | ||||||
| 08/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Diabetes | ||||||
| 08/20/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $72.92 | General |
| Category: WaveWriter Alpha_NMD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 336 | 402 | $88,610 | $23,099 |
| 2022 | 10 | 788 | 932 | $158,896 | $56,224 |
| 2021 | 10 | 870 | 1,072 | $194,108 | $74,302 |
| 2020 | 6 | 781 | 965 | $186,290 | $59,563 |
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 100 | 148 | $41,909 | $10,421 | 24.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 67 | 67 | $24,812 | $5,809 | 23.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 33 | 39 | $7,466 | $1,900 | 25.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 11 | 11 | $3,575 | $1,496 | 41.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 14 | 14 | $3,108 | $1,487 | 47.9% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 31 | 35 | $5,565 | $1,299 | 23.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 14 | 14 | $672.00 | $408.38 | 60.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 19 | 19 | $348.00 | $159.60 | 45.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 47 | 55 | $1,155 | $117.78 | 10.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 299 | 384 | $75,560 | $29,217 | 38.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 165 | 181 | $24,435 | $9,850 | 40.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 100 | 100 | $29,600 | $8,500 | 28.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 36 | 37 | $9,620 | $3,290 | 34.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 48 | 70 | $10,150 | $3,176 | 31.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 13 | $3,380 | $1,305 | 38.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 30 | 34 | $2,618 | $353.86 | 13.5% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2022 | 44 | 50 | $2,000 | $318.40 | 15.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 37 | 42 | $840.00 | $124.20 | 14.8% |
| 85610 | Blood test, clotting time | Office | 2022 | 17 | 21 | $693.00 | $88.80 | 12.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 419 | 553 | $108,447 | $43,480 | 40.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 198 | 220 | $29,738 | $12,011 | 40.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 91 | 91 | $26,984 | $9,528 | 35.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 60 | 99 | $14,355 | $4,734 | 33.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 30 | 30 | $5,850 | $1,909 | 32.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 11 | 11 | $2,860 | $1,148 | 40.2% |
About Michael Williamson
Michael Williamson is a Family healthcare provider based in Pinehurst, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/15/2018. The National Provider Identifier (NPI) number assigned to this provider is 1770091571.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michael Williamson has received a total of $2,867 in payments from pharmaceutical and medical device companies, with $1,250 received in 2024. These payments were reported across 141 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($2,820).
As a Medicare-enrolled provider, Williamson has provided services to 2,775 Medicare beneficiaries, totaling 3,371 services with total Medicare billing of $213,188. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Pinehurst, NC
- Active Since 01/15/2018
- Last Updated 01/15/2018
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1770091571
Products in Payments
- IBSRELA (Drug) $254.20
- ZEPBOUND (Drug) $167.67
- MAVYRET (Drug) $116.09
- Ozempic (Drug) $112.34
- INJECTAFER (Drug) $109.55
- Cologuard Collection Kit (Device) $108.16
- RINVOQ (Biological) $106.90
- MOUNJARO (Drug) $104.69
- JARDIANCE (Drug) $100.95
- VRAYLAR (Drug) $98.76
- WaveWriter Alpha Prime 16 (Device) $72.92
- Adlarity (Drug) $68.62
- YUPELRI (Drug) $67.88
- Wegovy (Drug) $65.45
- SKYRIZI (Biological) $57.98
- QUVIVIQ (Drug) $56.99
- Rybelsus (Drug) $51.90
- VOQUEZNA (Drug) $51.78
- LINZESS (Drug) $48.88
- XELJANZ (Drug) $47.76
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Pinehurst
Holly Mcguirk, Fnp-Bc, FNP-BC
Family — Payments: $8,863
Sue Ellen Bowes
Family — Payments: $6,852
Amy Cradic, Fnp-C, FNP-C
Family — Payments: $5,556
Constance Hall, Fnp-C, FNP-C
Family — Payments: $4,548
Laura Love, Np-C, NP-C
Family — Payments: $2,479
Mrs. Michele Hicks, Aprn, APRN
Family — Payments: $2,215